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Abstract
Mcl1 is a Bcl2-related antiapoptotic protein originally isolated
from human myeloid leukemia cells. Unlike Bcl2, expression
has not been reported in CNS neurons. We isolated Mcl1 in a
direct screen for candidate modifier genes of neuronal
vulnerability by differential display of mRNAs upregulated
following prolonged seizures in two mouse strains with
contrasting levels of hippocampal cell death. Mcl1 is widely
expressed in neurons, and transcription is rapidly induced in
both strains. In resistant C57Bl/6J mice, Mcl1 protein levels
remain persistently elevated in hippocampal pyramidal
neurons after seizures, but fall rapidly in C3H/HeJ hippo-
campus, coinciding with extensive neuronal apoptosis. DNA
damage and caspase-mediated cell death were strikingly
increased in Mcl1-deficient mice when compared to þ /þ
littermates after similar seizures. We identify Mcl1 as a
neuronal gene responsive to excitotoxic insult in the brain,
and link relative levels of Mcl1 expression to inherited
differences in neuronal thresholds for apoptosis.
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Abbreviations: 12 h SE, 12 h after pilocarpine-induced status
epilepticus; 24 h SE, 24 h after pilocarpine-induced status
epilepticus; ABC, avidin-biotinylated horseradish peroxidase
complex; BH, Bcl2 homology; BH3, Bcl2 domain 3 homology;
BSA, bovine serum albumin; C3H, C3H/HeJ; C57, C57Bl/6J;
CA3, Ammon’s horn subarea 3; CNS, central nervous system;
CTX, cortex; DAB, diaminobenzidine dihydrochloride; DbEST,
est; DG, dentate gyrus; DTT, dithiothreitol; ECL, enhanced
chemiluminescence; ER, endoplasmic reticulum; GAPDH, gly-
ceraldehyde-3-phosphate dehydrogenase; HPC, hippocampus;
HPF, high-powered magnification field; IL-6, interleukin-6; JAK,
Janus kinase; Klenow, Klenow fragment of DNA polymerase I-
mediated biotin-dATP nick-end labeling; MAPK, mitogen-acti-
vated protein kinase; Mcl1, myeloid cell leukemia-1; Mcl1-L,
myeloid cell leukemia-1 long isoform; Mcl1-S, myeloid cell
leukemia-1 short isoform; MEK, mitogen-activated protein kinase
kinase kinase; MRNA, messenger RNA; NGS, normal goat serum;
Nr, nonredundant; NS, Nissl staining; PAGE, polyacrylamide gel;
PBS, phosphate buffer saline; PFA, paraformaldehyde; PILO,
pilocarpine; RPA, RNase protection assay; RT, reverse-tran-
scribed; RT-PCR, reverse transcription-polymerase chain reac-
tion; SC, sense control; SDS, sodium dodecyl sulfate; SE, status
epilepticus; sm, scopolamine methyl nitrate; SSC, saline-sodium
citrate; STAT, signal transducer and activator of transcription;
TBS, Tris buffer saline; TdT, terminal deoxynucleotidyltransfer-
ase; TGFb, transforming growth factor beta; TUNEL, terminal
deoxynucleotidyl transferase-mediated dUTP end-labeling
Introduction
Neuronal vulnerability to apoptotic death following metabolic
stress, ischemia or seizures varies widely among inbred mouse
strains, suggesting that this threshold represents a complex
genetic trait determined both by genes known to regulate
apoptotic pathways as well as modifier loci in the genetic
background.1–6 This relationship has been clearly demon-
strated in the brain using targeted mutagenesis. For example, a
null mutation has been used to demonstrate that loss of p53, a
tumor-suppressor gene encoding an executioner protein,
protected against seizure-induced hippocampal cell death in
hybrid (129/SvC57BL/6) mice.7 However, subsequent ge-
netic dissection indicated that cell loss was extensive when the
p53 null mutation was studied on an inbred 129/Sv genetic
strain, implicating a strong contribution from C57BL/6 modifier
genes in the earlier study.8 The identity of these protective
modifier genes, which may also be responsible for the
differential resistance to cell death observed among other
mouse strains, is unknown. Leading candidates include a large
number of genes from diverse extracellular and intracellular
signaling pathways known to regulate neuronal viability, as well
as members of the proteolytic apoptosis cascade itself.
Mutations in such genes have also been linked to both
proliferative and degenerative cell-specific patterns of human
disease affecting the nervous system.9–11 The characterization
of wild-type modifier genes that raise the threshold for cell
damage in response to specific types of brain injury could help
pinpoint novel molecular targets for therapy based on
endogenous mechanisms of neuroprotection.
Two general approaches can be pursued to identify
neuroprotective modifier loci in vivo. The first utilizes
functional information and a candidate gene approach to
target the inactivation or overexpression of genes in known
apoptotic or antiapoptotic pathways and then to assess the
cytopathic effects of altering expression of these genes on
different genetic backgrounds. The lack of a complete list of
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genes within cell death pathways, the lethality of some null
mutants, and the large number of loci and strains that would
require extensive analysis make a systematic use of this
strategy prohibitive. An alternative approach takes direct
advantage of the dramatic differences in cell vulnerability that
already exist among various inbred strains of mice. Here we
show that the candidate gene approach in mice may be
effectively complemented by a reverse genomic strategy that
first identifies strain pairs with strong regional differences in
neuronal vulnerability, then selects for injury-induced strain-
specific differences in gene expression within these regions,
and finally evaluates the differentially expressed genes as
primary candidates for neuroprotection. This unbiased strat-
egy links variation in transcriptional regulatory cascades to
differential cell survival, and in contrast to microarray profiling
of pre-selected candidate mRNAs, isolates novel genes as
well as known genes within apoptotic pathways that have not
yet been localized to brain.
We first determined that C57BL/6J and C3H/HeJ, two
commonly studied inbred mouse strains, exhibited clear
differences in the degree of cell death following identical
episodes of hippocampal seizures. Pilocarpine, a muscarinic
cholinergic receptor agonist, is a widely used model of
prolonged seizures leading to an early and reproducible
pattern of hippocampal cell death.12 We then used differential
display of mRNA transcripts in a genome-wide search to
isolate genes that might contribute to this strain-specific
vulnerability. Unexpectedly, we identified Mcl1 as a gene that
strongly increased expression in hippocampus following
these seizures. Mcl1 is related to the antiapoptotic protein
Bcl2, and promotes survival of cultured cells under many
conditions that lead to apoptotic cell death.13–16 Although the
founder of this protein family, Bcl2, is considered a crucial
regulator of apoptosis in a wide variety of tissues, little
attention has been directed toward a role for Mcl1 in the central
nervous system since expression has been reported only in
brain epithelial cells and primary CNS tumors, but not in
neurons.17,18 We found that persistence of increased hippo-
campal Mcl1 protein levels in C57BL/6J, but not in C3H/HeJ
brain, correlated with neuroprotection in dentate and pyramidal
layer neurons. We used Mcl1-deficient mice to confirm the
antiapoptotic function of Mcl1 in brain. Heterozygous Mcl1 þ /
animals had more evidence of DNA damage after seizures
than their þ /þ littermates, demonstrating that Mcl1 has a
significant contribution to the neuronal apoptotic threshold
following brain injury.
Results
Strain differences in early apoptotic cell death
following seizures
We selected two inbred mouse strains, C57BL/6J and C3H/
HeJ, to determine whether genetic differences in thresholds
for excitotoxic cell death in the hippocampus could be
demonstrated following pilocarpine-induced (PILO) limbic
seizures. The acute behavioral features of PILO-induced
seizures in C57BL/6J and C3H/HeJ were similar to those
reported previously in rats and albino mice.19 In both strains,
PILO treatment induced a stereotyped pattern of behavioral
change beginning with akinesia and episodes of forelimb
clonus, progressing to recurrent generalized motor seizures
that continued as status epilepticus (SE). In order to
determine whether the effective convulsant dose was strain
dependent, PILO was administered (250–400 mg/kg) to both
C57BL/6J and C3H/HeJ mice and both seizure severity and
survival rates were assessed. At a dose of 250 mg/kg, C57BL/
6J showed immobility, followed by brief seizures without
progression to prolonged SE, while all C3H/HeJ mice showed
SE. At a dose of 350 mg/kg, C57BL/6J mice exhibited SE,
while the mortality was high in C3H/HeJ (6/6 mice died
immediately following PILO administration). The non-lethal
effective doses (250 mg/kg C3H/HeJ, 350 mg/kg C57BL/6J)
were selected for subsequent studies. Despite the strain
difference in convulsant dose, there were no significant
differences regarding seizure progression or duration, and
both strains showed SE lasting from 6 to 10 h.
To determine whether an identical interval of SE incurred
different degrees of hippocampal cell death between the
inbred strains, we performed cresyl violet staining and
terminal deoxynucleotidyl transferase-mediated dUTP end-
labeling (TUNEL) on mouse brains killed 12 or 24 h after SE
onset. Serial sections counterstained for Nissl substance
within intact neuronal cell bodies showed disorganization of
the pyramidal cell layer in both strains and neuronal cell
damage beginning to appear at 12 h after PILO administra-
tion; however, few or no cells exhibited positive TUNEL
staining and there was no detectable difference in the pattern
of cell death in either strain. After a 24 h survival period
following SE, Nissl staining revealed a striking increase in
shrunken cells with pyknotic nuclei in CA1 and CA3 subareas
of C3H/HeJ compared to C57BL/6J mice. Selective TUNEL
staining of cell clusters in CA1 and CA3 subareas was clearly
evident in both strains; however, despite the lower dose of
pilocarpine administered, a greater than three-fold increase in
apoptotic cells was found in the pyramidal cell layer of C3H/
HeJ compared to C57BL/6J mice (C3H: 104.175.2 S.D.,
n¼ 7; C57: 33.576.6 S.D.; n¼ 7; Po0.001; mean number of
cells per high-powered field). The highest percentage of
apoptotic cells was located within the CA3 region (Figure 1a).
C3H/HeJ PILO-treated mice exhibited a small number of
TUNEL-labeled cells in DG and other hippocampal regions,
but there was no significant difference compared with the
same region in C57BL/6J animals (Figure 1b).
Strain comparison of genes regulated by SE
We performed a differential display of mRNA transcripts from
hippocampi excised from C57BL/6J and C3H/HeJ mice killed
12 h after PILO-induced SE to screen for potential differences
in early gene expression between these strains. Approxi-
mately 150 candidate RT-PCR products were identified that
were differentially expressed after SE. In all, 10 products
showing the most striking differences were eluted from the
dried polyacrylamide gels, reamplified by PCR, T/A-cloned,
and sequenced. Sequences were then used to query the
nonredundant (nr) and est (dbEST) nucleotide divisions of
GenBankt using BLASTN, and the nr protein division using
BLASTX. Three of the 10 clones were unambiguously
identified; of these, clone 24a showed a high level of
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sequence similarity to the human Mcl1 gene (Myeloid Cell
Leukemia-1; GenBank BC005427; OMIM 159552) and was
selected for further study. Mcl1 mRNAs for both human (NCBI
UniGene Database Cluster Hs.86386) and mouse (NCBI
UniGene Cluster Mm.1639) are represented in numerous
nervous system tissue samples.
A single Mcl1 spliceform is expressed in adult
mouse hippocampus
Two mRNA splice variants of Mcl1 have been described in
human tissues; a full-length form (Mcl1-L), which has
homology in the C-terminal transmembrane region to Bcl-2
and confers an antiapoptotic function, and a short form (Mcl1-
S) with a proapoptotic function.20,21 To determine which form
was being expressed after prolonged seizures, we performed
RT-PCR on total RNA extracted from the dissected hippo-
campi of adult C3H/HeJ and C57BL/6J mice killed 12 h after
either injection of saline or seizure-inducing pilocarpine
induced seizures. The products were eluted, purified, and
sequenced, and the sequences aligned to human Mcl1-L and
Mcl1-S. Mcl1-L, which bears an antiapoptotic function in
human cells, was the only form detected in C3H/HeJ or
C57BL/6J mouse hippocampus (Figure 2).
In situ hybridization of Mcl1 in mouse brain
Since Mcl1 expression has not been previously localized in
the brain, the distribution of Mcl1 mRNA was determined by in
situ hybridization to brain sections from untreated C57BL/6J
and C3H/HeJ mice. Regional Mcl1 mRNA distribution was
diffuse in both strains, and no inter-strain pattern differences
were observed (Figure 3a). The strongest labeling pattern
was observed in the hippocampal formation, with intense
labeling of pyramidal cells in Ammon’s horn and granule cells
in the dentate gyrus. A strong hybridization signal was also
present in neurons in the piriform cortex, entorhinal and
perirhinal cortices, amygdala, medial habenula, and the
posterior hypothalamic area. Mcl1 mRNA levels were
elevated 12 h after an episode of SE. Increased limbic
expression following seizures was identified in both strains,
and was most prominent in pyramidal and granule cells in the
Figure 2 Pilocarpine-induced seizures do not alter Mcl1 mRNA splicing in
C57BL/6J or C3H/HeJ mouse brain. (a) RT-PCR analysis of RNA extracted from
C57BL/6J and C3H/HeJ brains 12 h after injection of saline or seizure-inducing
amounts of pilocarpine. A single product was detected in all samples,
corresponding to exons 1–3 of Mcl1 (433 bp, black arrowhead). Skipping of
exon 2, which generates a proapoptotic form of Mcl1 in some human tissues, was
not observed in mouse hippocampus following seizures (185 bp, open
arrowhead). (b) Comparison of human and mouse Mcl1 gene structures. Mature
mRNA transcripts excluding exon 2 are only reported from human tissue. Thick
white bars, 50 and 30 untranslated regions; thick black bars, coding regions; thin
black bars, introns; arrows, primers used for RT-PCR. Diagonal lines indicate
confirmed splice patterns. The gray box indicates a region of striking sequence
dissimilarity between human and mouse Mcl1. Sizes shown are for coding
segments only
Figure 1 Selective vulnerability to hippocampal cell death in two inbred mouse
strains. (a) Limbic SE resulted in neuronal damage and TUNEL-positive staining
in the hippocampal CA3 region in C57BL/6J and C3H/HeJ mice 24 h after
pilocarpine administration. Bar¼ 50 mm. (b) Regional quantification indicates
that TUNEL staining is increased greater than three-fold in the CA3 area in C3H/
HeJ mice compared with the more resistant C57BL/6J mouse brain. Control:
saline control; 24 h SE: pilocarpine-induced SE; HPF: high-powered magnifica-
tion field; CA3: Ammon’s Horn subarea 3; DG: dentate gyrus including hilar
polymorphic cell region
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hippocampal formation, and in the piriform cortices
(Figure 3b). There is a very low level of nonspecific binding
after probing with the sense probe (Figure 3c). The Nissl
staining shows the neuronal areas, which co-localize with the
in situ labeling for Mcl1 (Figure 3d).
RNase protection assay of Mcl-1
To quantify the altered gene expression found with differential
display and in situ hybridization, we performed RNase
protection assays (RPAs) using Mcl1 riboprobes and hippo-
campal total RNA extracted 12 h following either saline or
SE-inducing PILO injections in both C57BL/6J and C3H/HeJ
strains. Three independent RPA experiments were per-
formed. The amount of protected probe was quantified by
densitometry of the autoradiographs, and normalized to the
housekeeping gene glyceraldehyde-3-phosphate dehydro-
genase (GAPDH; GAPDH¼ 1; Figure 4). Despite an apparent
difference based on differential display screening, basal
quantitative levels by RPA assay did not statistically differ
between strains. However, in both strains, hippocampal Mcl1
mRNA levels were significantly increased (mean C57BL/6J
þ 76%, range þ 48 to þ 133%; mean C3H/HeJ þ 111%,
range þ 87 to þ 157%; Po0.05) relative to saline-treated
control mice of the same strain 12 h after seizures.
Subcellular distribution of Mcl-1 in murine
neurons
Immunostaining of limbic regions in mouse brain with anti-
Mcl1 antibody showed a diffuse labeling of neurons through-
out the neocortex and in pyramidal and dentate granule cell
layers within the hippocampal formation. Neurons were
clearly labeled by Mcl1 antibody in most layers of the
neocortex, although there was preferential staining of larger
excitatory cells. In the hippocampal formation, there was
strong labeling of dentate granule cells, pyramidal neurons
throughout the CA1–4 regions and subiculum, and adjacent
entorhinal cortex. We examined the subcellular localization of
Mcl1 staining in neurons in mouse brain tissue (Figure 5a).
There was a punctate, and occasionally diffuse cytoplasmic
pattern sparing the nucleus, generally associated with intense
staining near the plasma and nuclear membranes, as
described previously in other non-neuronal cell types.22–24
While staining was most intense in the somatic compartment,
immunostaining within large pyramidal neurons was often
seen extending away from the soma into the proximal and,
rarely, the distal compartments of apical and basilar dendrites.
Diminished Mcl1 immunoreactivity in regions of
maximal hippocampal cell loss in C3H/HeJ mice
Limbic seizures increased the intensity of staining in the
hippocampus within 12 h in both strains, and at this time point
Mcl1 immunoreactivity was greater in the apoptosis-resistant
C57 strain (Figure 5b). By 24 h, the maximal intensity staining
Figure 3 Seizures induce Mcl1 transcription in cell death-resistant (C57BL/6J)
and sensitive (C3H/HeJ) mouse strains. In situ hybridization of adult mouse brain
in (saline-treated animals.) (C) and after pilocarpine-induced SE reveals that
Mcl1 mRNA is widely expressed in the brain of both strains, and increases within
12 h following seizures. Seizure-induced Mcl1 expression is most striking in the
dentate granule cell and pyramidal cell layers of hippocampus (black and white
arrowheads, respectively) as well as in piriform cortex (white arrow). Sense
controls (SC) for each strain are shown in third row. The Nissl staining (NS)
shows the neuronal cell layers for comparison with corresponding regions in the
in situ labeling. Photoshop inverted color masking was used in original digital
pictures
Figure 4 Quantitative ribonuclease protection of Mcl1 mRNA induction by
seizures. (a) Protection of Mcl1 and GAPDH riboprobes by C57BL/6J (C57) and
C3H/HeJ (C3 H) hippocampal RNA extracted 12 h after seizure induction. (b)
Densitometry profile of the autoradiograph shown in (a). Dashed lines demarcate
the specific regions quantified. (c) Comparison of mean levels of protected
riboprobe from three replicate strain-pair comparison experiments, with Mcl1
levels normalized to GAPDH, indicates a significant increase in Mcl1 following
seizures in both strains (C). Control; 12 h SE: 12 h after pilocarpine-induced SE
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(4þ ) in hippocampal fields persisted in C57 brain; however,
the same regions in C3H mice showed a clear loss of staining,
returning to the moderate baseline intensity (2þ ). This
reduction was most striking in regions also showing the most
significant levels of cell death, including the hippocampal
dentate and pyramidal cell layers. There were no significant
changes in the intensity of immunoreactivity evident in other
areas of the limbic cortex or related subcortical nuclei. These
results were confirmed by Western blotting for Mcl1 that
revealed a significant increase (30–47%, Po0.05) in the
hippocampal protein levels in both strains 12 h after SE. Mcl1
levels remained elevated during the 24 h period following SE
in C57 hippocampus, yet decreased during this interval by
25% in C3H animals (Po0.05) (Figure 5c).
Mcl1 protects against early apoptotic cell death
following SE
To confirm the antiapoptotic function of Mcl1 in neurons as
previously shown in other tissues, mice with a targeted
deletion of the Mcl1 gene,25 (129SvJ/C57BL6 Mcl1/þ ) and
þ /þ littermates, were injected with pilocarpine (350–370 mg/
kg) and then compared for differences in the extent of seizure-
induced hippocampal cell death. Since homozygous deletion
of Mcl1 results in peri-implantation embryonic lethality, only
þ / animals could be used. PILO was administered (300–
370 mg/kg) to Mcl1 þ /þ (n¼ 15) and þ / (n¼ 14) mice and
seizure severity and survival rates were assessed in order to
verify whether the lack of one copy of the Mcl1 gene would
alter the susceptibility to PILO-induced seizures. At a dose of
350 mg/kg, most wild-type animals showed a single brief
seizure consisting of immobility, followed by forelimb and tail
extension without progression to SE, while all heterozygotes
showed prolonged SE. At a dose of 370 mg/kg, wild-type mice
exhibited SE, while the mortality was high (3/3) in hetero-
zygotes. The nonlethal effective doses (350 mg/kg for þ /
and 360 mg/kg for þ /þ ) were selected for subsequent
studies. There were no significant differences regarding
seizure progression or duration, and both genotypes showed
SE lasting from 6 to 10 h.
Figure 5 Strain-specific differences in Mcl1 protein following seizures. (a) Subcellular localization of Mcl1 in murine neurons. Mcl1 is widely distributed in mouse brain,
and shows strong persistent expression in pyramidal cells of (C57BL/6J þ /þ ) mouse hippocampus (HPC) and neocortical neurons (CTX) injured by seizure-induced
cell death. Mcl1 immunoreactivity shows a perinuclear cytoplasmic localization, extending in larger pyramidal neurons into thicker proximal and apical dendrites.
Bar¼ 50 mm. (b) Decreased level of Mcl1 immunoreactivity in C3H/HeJ hippocampus correlates with increased seizure-induced neuronal apoptosis. Hippocampal
sections from cell death-resistant (C57BL/6J) and sensitive (C3H/HeJ) mice before seizures (control animals) show baseline immunostaining levels (1–2þ ), with low to
moderate levels apparent in the pyramidal layer (arrow) and dentate granule cell layer (small arrowhead) of both strains. At 12 h after seizure onset (12 h SE), a striking
increase (4þ ) in Mcl1 immunoreactivity is evident in C57 pyramidal and dentate cell layers, and lesser (3þ ) increase is observed in C3H. By 24 h (24 h SE), Mcl1
immunostaining in C57 hippocampus remains above pre-seizure levels, but has dropped in C3H to pre-seizure levels. Bar¼ 400 mm. (c) Histogram showing the results
of triplicate Western blotting for Mcl1 protein expression quantifying the differences in the hippocampal protein levels observed by immunohistochemistry, and a
representative blot. Blots were probed with anti-Mcl1 and anti-actin as an internal control. There is a significant increase of the Mcl1 protein levels in the period of 12 h
after SE in both C3H and C57 strains compared to the control animals (30–47%) (Po0.05). At 24 h after SE, Mcl1 protein levels remain significantly elevated in both
strains; however, C57 animals were 25% higher than in C3H hippocampi (Po0.05), and levels in C3H mice significantly declined by 20%. C: saline control; 12 h SE: 12 h
after SE; 24 h SE: 24 h after SE. Bar¼ 400 mm
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To determine whether Mcl1 deficiency alters the threshold
for hippocampal cell death after SE, we examined the Klenow
fragment of DNA polymerase I-mediated biotin-dATP nick-
end labeling (Klenow) for single- and double-stranded DNA
breaks, and immunohistochemistry for the activated form of
caspase 3. Mcl1-deficient (þ /) and þ /þ mice were killed
24 h after SE onset. Minimal Klenow labeling was detected in
the hippocampus of saline-treated animals of both genotypes
(A, B), whereas there was a striking increase in the number of
labeled cells, demonstrating evidence of DNA breaks in the
CA3 pyramidal cell layer and other hippocampal subareas of
Mcl1 þ / animals when compared to Mcl1 þ /þ mice
(Figure 6c, d). Activated caspase 3 immunoreactivity was also
twice more intense (4þ ) in Mcl1-deficient mice (F) than wild-
type littermates (2þ ) following seizures (E). The table in
Figure 6g shows the three-fold increase in the number of
Klenow-labeled cells in animals Mcl1 þ / after seizures
compared to their nonaffected littermates (Mcl1 þ /þ SE
6176 S.D., n¼ 8; Mcl1 þ / SE: 191719 S.D.; n¼ 7;
Po0.001; mean number of cells per high powered field;
Po0.001).
Discussion
We used differential display of hippocampal mRNAs to screen
for genes that could contribute to strain-specific differences in
vulnerability to apoptotic neuronal cell death following
prolonged seizures, and identified Mcl1 expression in brain.
Expression of the full-length antiapoptotic Mcl1-L transcript
(but not the proapoptotic short form, Mcl1-S) was rapidly
upregulated in both sensitive (C3H/HeJ) and resistant
(C57BL/6J) strains; however, by 24 h Mcl1 protein levels fell
dramatically in the sensitive strain. The sustained presence of
Mcl1 protein in surviving cells in the resistant C57 strain, and
its rapid decrease in cell layers undergoing apoptosis in the
sensitive C3H strain, together with the striking increase in
seizure-induced DNA damage within 24 h of a prolonged
seizure in Mcl1 þ / mice, provide the first evidence for a
protective, inducible role of this protein in neurons in response
to brain injury.
Mcl1 belongs to the Bcl2 family of antiapoptotic
proteins
Mcl1 is a member of the prosurvival Bcl2 family that
constitutes a crucial regulatory point in the mitochondrial
pathway leading to apoptosis in a wide variety of tissues.
These proteins localize predominantly to mitochondrial
membranes, controlling their permeability to cytochrome c
and Diablo/Smac, and hence downstream activation of the
apoptosome complex that initiates a caspase cascade leading
to programmed cell death.26 Antiapoptotic proteins such as
the proto-oncogenes Bcl2 and Mcl1 heterodimerize with
proapoptotic proteins such as BAD, BOD, Bim, Bik, Bok,
and Bax to regulate this death pathway.27–30 The relative
activity of these competing genes, as well as transcription-
independent control mechanisms, may determine the apop-
totic threshold of the cell. Distribution and expression levels of
the individual members are cell, tissue, and differentiation-
stage specific, permitting highly selective activation of the cell
death program in development and disease.31–33
Mcl1 bears significant carboxyl terminus homology (BH1-3
domains) to Bcl-2, and was discovered during a screen for
genes that increase expression early in the phorbol ester-
induced differentiation of human ML-1 myeloblastic leukemia
cells.13 Mcl1 is located predominantly on mitochondrial outer
membranes,23,24 and promotes survival of cultured cells in
vitro under many conditions in which cell death occurs due to
apoptosis, including growth factor withdrawal, cytotoxic
chemical insult, and radiation.14–16,34 In vitro depletion of
Mcl1 mRNA and protein by antisense treatment leads to rapid
apoptosis of myeloid leukemia cells within 4–18 h,35,36 and
overexpression in hematolymphoid tissues causes dissemi-
nated lymphomas of B-cell origin.37 The relative contribution
of Mcl1 is strongly dependent upon cell type; for example,
Figure 6 Increased susceptibility to seizure-induced neuronal DNA damage
and apoptosis in Mcl1-deficient mice. (a, b) No Klenow staining was evident
following saline control injections into Mcl1 þ / or þ /þ mice. (c, d)
Prolonged seizures produced DNA damage and Klenow-positive staining in the
hippocampal CA3 region in Mcl1 þ /mice 24 h after pilocarpine administration.
An intense labeling in neurons within the CA3 pyramidal cell layer is present in
þ / mice compared with the Mcl1 þ /þ mouse brain after seizures. (e, f)
Higher immunoreactivity (4þ ) for caspase 3 was detected in Mcl1 þ / mice
24 h after SE compared to Mcl1 þ /þ mouse brain (2þ ). (g) Regional
quantification indicates Klenow-labeled cells three times higher in the CA3 area in
Mcl1 þ / mice compared with their nonaffected littermates þ /þ after
seizures (Po0.001). Control: saline control; 24 h SE: pilocarpine-induced SE;
HPF: high-powered magnification field; CA3: Ammon’s Horn subarea 3; Bars
denote (a–d) 70 mm, (e, f) 20 mm
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Mcl1 is the principle antiapoptotic protein in the ovary, while it
has a more complex role in other tissues.16
MCl1 is active in the apoptotic pathway in CNS
neurons
We found diffuse expression of Mcl1 mRNA in mouse brain
and a low level of Mcl1 immunoreactivity within murine
neurons. Following seizures, the intracellular localization
resembles the cytoplasmic staining pattern surrounding the
nucleus, mitochondria, and in the endoplasmic reticulum
(ER), as seen in lymphoid cells. The intensity of Mcl1
immunoreactivity is known to vary widely among tissues and
specific cell types, and is particularly intense in malignant
brain neoplasms, including primary central nervous system
(CNS) lymphomas and tumors of glial and neuroectodermal
origin.17,18,38 Although those studies found neurons in
peripheral dorsal root ganglia that were moderately stained,
essentially no neuronal immunoreactivity was reported in the
human CNS in these studies. As a result, Mcl1 has remained
absent from various lists of candidate genes for cell-death
molecules in the nervous system.31,32,39,40 Since the same
antibody to Mcl1 was employed in this study, the disparate
immunocytochemical findings are likely explained by the
lower antibody titers previously used to examine human
neoplastic tissue (1 : 800–1000) compared with the concen-
tration (1 : 200) used in this study, and the fact that neurons
were more intensely stained following upregulation by
seizures.
Functional link of Mcl1 to neuroprotection in
epileptic brain
Several lines of evidence suggest that Mcl1 directly con-
tributes to the neuroprotection observed in vivo in C57 mice.
First, we found that only the long spliceform of Mcl1 is
preferentially expressed in neurons. The human Mcl1 protein
has long and short splice variants, with contrasting anti- and
proapoptotic properties, respectively.20,21 The long splice
variant produces a prosurvival protein with Bcl2 homology
(BH) in domains 1, 2, and 3 and the C-terminal transmem-
brane region, allowing interactions with diverse Bcl2-related
proteins that are lost in the truncated (BH3 only) variant.
Second, activation of Mcl1 begins in the interval preceding
the onset of apoptosis. In the initial 12 h following pilocarpine-
induced seizures, both the sensitive and resistant inbred
strains showed early upregulation of Mcl1 in regions where
Klenow-positive DNA breakage, and later TUNEL-positive
cell damage, occurs. This early period following seizures
coincides with significant upregulation of Bcl2, activation
of Fas and FADD death receptor signaling, and caspase-
mediated activation of a large number of proteins regula-
ting pro- and antiapoptotic control points in the seizure-
induced cell death pathway.41,42 Mcl1 is upregulated by
cytokines such as interleukin-6 (IL6) acting through the JAK/
STAT pathway and interferon alpha,43–46 by activin via the
TGFb pathway47 and by MEK, implicating the Ras/MEK/
MAPK pathway in Mcl1 transcription.48 Since activity within
these linked pathways increases rapidly in CNS ischemia and
epilepsy,49–51 the elevated transcription of Mcl1 may depend
on the participation of a wide range of early inflammatory
response signaling in the brain. The prompt elevation of Mcl1
expression in both mouse strains after SE suggests that the
protein is involved in the earliest response to cell injury, and
that upstream regulation is not differentially impaired in the
two strains studied.
Third, increased hippocampal Mcl1 immunoreactivity per-
sists in the seizure- and cell death-resistant C57 strain.
Elevated levels of Mcl1 protein remained in C57BL/6J
hippocampus throughout the 24 h period when apoptotic cell
death was initiated, whereas a steep drop in Mcl1 levels
coincided with the more extensive pattern of neuronal cell loss
in C3 H hippocampus. The Mcl1 protein is highly labile, with a
half-life ofB3 h,23,24 and it is unknown how tightly translation
is coupled to steady-state mRNA levels in neurons. These
data suggest that a further post-transcriptional step may
explain the strain differences in cell vulnerability. Further
genetic analyses of these two mouse strains may reveal
polymorphisms in Mcl1, in other genes such as the serine/
threonine kinase Akt-1 gene,52 or in various proteases that
may account directly for differential Mcl1 protein translation or
stability.
Our findings demonstrate that Mcl1 has an important
antiapoptotic role in neurons, as demonstrated by the
enhanced presence of Klenow labeling of single-stranded
DNA breaks in the hippocampus of Mcl1-deficient mice but not
þ /þ mice after SE. Activated caspase-3 immunohistochem-
istry showed an increased staining intensity in Mcl1-deficient
mice 24 h after seizures, indicating that the induction of DNA
damage proceeds via caspase-activated deoxyribonuclease.
The presence of early Klenow labeling only in Mcl1-deficient
mice indicates that Mcl1 acts as an immediate early gene to
prevent cell damage in the first 24 h after SE, since single-
strand DNA breaks appear to precede double-strand breaks
and delayed cell death in other settings.53,54
Genomics of neuronal vulnerability in the CNS
We have linked the Mcl1 gene to the increased threshold for
seizure induced cell death in C57BL/6J mice compared with
C3H/HeJ; however, it is unknown whether this or any single
gene accounts for all of the neuroprotection differentiating this
strain pair. In addition, while it does not require linkage
mapping, the strategy of comparative gene expression
profiling isolates only transcriptional differences, and is
insensitive to coding polymorphisms altering protein function
that might also contribute to variable resistance between the
two strains. It is important to emphasize, however, that Mcl1
and the other candidates for regulating differential neuropro-
tection identified in this study were isolated from what are
traditionally considered wild-type mouse strains, and not from
mice carrying spontaneous or targeted mutations that
produce deleterious phenotypes. This strategy therefore
helps define the pool of alleles in a general population that
are not strictly classified as mutations, but that nonetheless
encode a latent susceptibility to tissue injury. Such genes may
play an important role in the differential pathological impact
of inherited and acquired neurological disorders among
individuals. The congruence of induced Mcl1 mRNA and
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protein expression with the lowered threshold for damage in
Mcl1-deficient mouse brain demonstrates that this member of
the Bcl2-related protein family is involved in the apoptotic
pathway in central neurons, and may now be included in the
list of molecules that modify vulnerability to cell death in both
rapid and slow neurodegenerative disease.
Materials and Methods
Seizure induction by pilocarpine
Adult mice (2–3 months of age) of two inbred strains, C57BL/6J and C3H/
HeJ, were obtained from breeding colonies of the Jackson Laboratory (Bar
Harbor, Maine); Mcl1 þ / and þ /þ mice were obtained from the
colony at Dana Farber Cancer Institute (Boston, MA, USA), and were
housed under a 12 h light/dark cycle with ad libitum access to food and
water. Status epilepticus was induced by intraperitoneal injection of
pilocarpine hydrochloride (PILO) (Sigma, St. Louis, MO, USA).
Scopolamine methyl nitrate (sm) was given 30 min prior to PILO in order
to minimize peripheral autonomic effects. Pilocarpine (4%) was dissolved
in saline and administered (350 mg/kg i.p. for C57BL/6J; 250 mg/kg for
C3H/HeJ; 350 mg/kg Mcl1 þ /; 360 for Mcl1 þ /þ ) at doses
determined by the seizure threshold and mortality rate in these strains
to reliably produce seizure episodes lasting 6 h with survival. Control
animals, C57BL/6J, C3H/HeJ, Mcl1 þ /, and þ /þ were injected with
sm and equal volumes of 0.9% saline instead of PILO.
Apoptosis detection
Groups of C57BL/6J, C3H/HeJ, Mcl1 þ /, and þ /þ mice were
decapitated at 12 or 24 h after the onset of behavioral SE. Whole brains
were rapidly removed, frozen in isopentane (401C), and stored at
801C. Coronal sections (16 mm thickness) were used for TUNEL,
Klenow labeling, and caspase-3 immunohistochemistry.
Detection of DNA strand breaks by TUNEL labeling
assay
Sections were formalin fixed at 41C overnight, washed in 0.1 M
phosphate buffer saline (PBS), pH 7.4, post-fixed in pre-chilled
ethanol:acetic acid (2 : 1) for 5 min at 201C. The slices were washed
twice in PBS and quenched in 3% H2O2, rinsed in PBS and incubated in
equilibration buffer for 10 s at room temperature, followed by incubation
with terminal deoxynucleotidyltransferase (TdT) (Promega, Madison, WI)
in a humid chamber at 371C for 1 h. Slices were washed in PBS and
incubated with anti-digoxigenin peroxidase conjugate at RT for 30 min.
Labeling was revealed by application of diaminobenzidine dihydrochloride
(DAB). Sections were counterstained with cresyl violet to determine
neuronal cell loss.
Detection of DNA strand breaks using Klenow
labeling assay
DNA strand breaks were detected on adjacent sections using the Klenow–
FragEL kit (Oncogene, San Diego, CA, USA). Briefly, sections were fixed
with 4% PFA in PBS for 15 min, washed for 5 min each in TBS, incubated
in 2 mg/ml proteinase K in 10 mM Tris (pH 8.0) for 10 min and then washed
three times for 5 min each in TBS. After the sections were quenched
with 3% H2O2 in methanol for 5 min, they were incubated in a humidified
air chamber at 371C for 1 h in the equilibration buffer (0.5 M Tris
(pH 8.0), 0.5 M NaCl, 0.1 M MgCl2) for 30 min, followed by incubation in a
labeling mixture containing labeled and unlabeled deoxynucleotides and
Klenow enzyme for 1.5 h. The reaction was terminated by washing the
slides in the stop buffer (0.5 M EDTA, pH 8.0) for 5 min, and then
incubated for 5 min in 4% bovine serum albumin in PBS, the slides were
incubated with streptavidin/horseradish peroxidase in PBS/bovine
serum albumin (BSA) for 30 min at room temperature. The biotin/
streptavidin/peroxidase complex was detected by incubating the sections
with 0.5 mg/ml DAB in PBS and 0.05% H2O2. Sections were dehydrated
and coverslipped.
Caspase 3 immunohistochemistry
Adjacent sections were incubated in antigen retrieval solution (Dako,
Carpinteria, CA, USA), microwaved for 2 min, incubated for 1 h with 1.5%
normal goat serum (NGS) in 0.01 M Tris Buffer Saline (TBS, 100 mM Tris–
HCl, 1.5 M NaCl, pH 7.4), then incubated with anti-caspase antibody
(1 : 200, Trevigen, Gaithersburg, MD, USA) 1.5% NGS, and 0.25%Triton
X-100 overnight at 41C. After washing in TBS, sections were incubated in
biotinylated anti-rabbit antibody (1mg/ml) diluted in TBS with 1.5% NGS
for 30 min, rinsed, and incubated in avidin-biotinylated horseradish
peroxidase complex (rabbit ABC staining system, Vecstain, Vector labs,
Burlingame, CA, USA) for 30 min. The peroxidase reaction was detected
by application of DAB/TBS for 3 min, the sections were rinsed and
mounted on slides, dehydrated, cleared, and coverslipped. Regional
staining intensity was graded on a 0–4 scale (0¼ no visible staining,
4¼ intense staining).
Differential display (DD)
Mice were killed 12 h after initiation of SE. Hippocampi from were
dissected and immediately frozen on dry ice. TRIzol reagent (Life
Technologies) was used to isolate total RNA according to the
manufacturer’s protocol. To minimize potential DNA contamination, RNA
samples were treated with RNase-free DNase I (GenHunter, Nashville,
TN, USA). To assess RNA integrity, samples were visualized after
electrophoresis through 1.0% agarose gels containing ethidium bromide.
Yield and purity were assessed by spectrophotometry. The DD technique
was performed using the recommended reagents and manufacturer’s
protocols supplied with the RNA image kits (GenHunter). Briefly, total RNA
isolated from the hippocampus of SE and control animals as described
above was reverse-transcribed (RT) in a 20 ml reaction using anchored
oligo(dT) primers. In all, 2ml of the RT reaction was used in PCR with
arbitrary 13-mers and anchored oligo(dT) primers in the presence of
[a-32P]-dATP according to the methods of Liang et al.55 The products were
size-fractionated on 6% denaturing polyacrylamide gels (PAGE) and
visualized by autoradiography. The autoradiographs were examined to
identify cDNA bands satisfying the following criteria: differential intensity
exhibited between PILO-induced C3H/HeJ mice and PILO-induced
C57BL/6J mice, when compared to the saline-treated C3H/HeJ and
C57BL/6J control mice. These criteria ensured that cDNAs chosen for
further analysis would reflect strain-specific alterations due to SE and not
those caused by strain variation alone. Bands satisfying these criteria were
excised from the dried polyacrylamide gels, and the cDNA eluted,
reamplified by PCR, and T/A-cloned into the plasmid vector pGEM-T
(Promega) according to the manufacturer’s instructions. The resulting
clones were sequenced and clone identity was determined using BLASTN
alignments to GenBank nr, dbEST, and HTGS database subsets, with
default parameters.
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Reverse transcription and polymerase chain
reaction assay (RT-PCR)
RT-PCR was performed according to the manufacturer’s protocol (Access
RT-PCR system, Promega). Total RNA was isolated from mouse
hippocampus as described above and reverse transcribed (RT) using
AMV reverse transcriptase and random hexamers, and the mixtures
incubated at 481C for 45 min followed by 941C for 2 min. For PCR
amplification of Mcl1, the cDNA template resulting from RT of 0.1mg
equivalent of total RNA was used in a 50 ml reaction. The primers were:
Mcl1 forward [50-AGATCATCTCGCGCTACTTGC-30] and Mcl1 reverse
[50-AGGTCCTGTACGTGGAAGAACTC-30] (Sigma-Genosys, TX, USA).
Amplification consisted of 40 cycles (941C for 30 s, 601C for 1 min, 681C
for 2 min), followed by incubation at 681C for 7 min. In all, 5 ml of loading
dye was added to 15 ml of sample, electrophoresed through a 1% agarose
gel containing ethidium bromide, and visualized by UV illumination. There
are two isoforms for Mcl1, a long form constituted by 433 base pairs and a
short form of 185 base pairs, only the long form was detected by the RT-
PCR. The bands were eluted, purified from the gel (Qiagen, Chatsworth,
CA, USA) and the cDNAs sequenced for authentication.
In situ hybridization
Oligonucleotide probes were constructed from sequenced clones. In situ
hybridization was performed as outlined by Burgess et al.56 A 45-mer
antisense oligonucleotide probe was designed to nonconserved regions of
the mouse Mcl1 cDNA [50-CCTAACCCTTTCGGGAACAGCTGT-
TAAAGTGTTAGGTGCTCTACC-30] (Sigma-Genosys, TX, USA). Probes
were 30 end-labeled using TdT (Promega) and deoxyadenosine 50-
[a-35S]thiotriphosphate (1250 Ci/mmol; NEN) to a specific activity of
109 dpm/mg. Unincorporated oligonucleotides were removed using Bio-
spin 6 chromatography columns (Bio-Rad, Hercules, CA, USA) and
dithiothreitol (DTT) was added to a final concentration of 20 mM. C3H/HeJ
and C57BL/6J mice were killed by cervical dislocation 12 h after the onset
of SE and 12mM brain sections from these and sex/age/strain-matched
controls were cut in a cryostat and thaw-mounted onto Superfrost/Plus
glass slides (Fisher). Sections were fixed in 4% paraformaldehyde (PFA)
in PBS, rinsed in PBS and dehydrated in an ascending ethanol series. The
hybridization solution contained 50% (v : v) formamide, 4 saline-sodium
citrate (SSC), 25 mM sodium phosphate, 1 mM sodium pyrophosphate,
10% dextran sulfate (w : v), 5Denhart’s solution, 200 mg/ml sonicated
(100–600 bps) herring sperm DNA (Promega), 100 mg/ml polyadenylic
acid [50] (Sigma Aldrich, St. Louis, MO, USA), and 5 102 dpm of
deoxyadenosine 50-[a-35S]thiotriphosphate-labeled oligonucleotide probe.
Nonspecific hybridization was assessed by hybridization of selected
sections in the presence of an additional 100-fold unlabeled oligonucleo-
tide. Sections were hybridized under Parafilm coverslips overnight at
421C, prior to washing in 1 SSC at room temperature for 20 min,
0.3 SSC at 551C for 4 min, and 2 SSC at room temperature for 5 min.
All washing solutions contained 10 mM DTT. Sections were dehydrated in
an ascending ethanol series and exposed to Kodak (Rochester, NY)
BioMax MR film for 2–5 days. Developed autoradiographs were digitized
(Sprintscan 35, Polaroid, Cambridge, MA, USA) and arranged using
Photoshop 5.0 (Adobe systems, San Jose, CA, USA).
Ribonuclease protection assay
RPA was utilized to confirm and quantify differences in gene expression
obtained by DD. Total RNA preparations from homogenized mice
hippocampi were hybridized with cRNA probes followed by digestion with
RNAse using protocols and reagents supplied in the RNAse Protection kit
(Ambion). Briefly, 5 mg of total RNA was co-precipitated with 1–
3 105 cpm [32P]-UTP-labeled in vitro-transcribed mouse Mcl1 cRNA,
then dissolved in 20ml hybridization buffer. The housekeeping gene
GAPDH cRNA was used for normalization. Reaction mixtures were heated
to 951C for 5 min and incubated overnight at 451C. A mixture of RNaseA/
T1 was then added to digest single-stranded RNA, while the cRNA
fragments hybridized to the endogenous sense mRNA and were protected
from RNAse digestion. The protected cRNA fragments were precipitated
with isopropanol and the pellets resuspended in 5 ml gel loading buffer,
denatured at 951C, and fractionated by 6% PAGE. The gel was fixed,
dried, and analyzed by autoradiography. Bands representing protected
fragments were digitally quantified using Scion-Image/NIH image
software.
Reverse transcription and polymerase chain
reaction assay (RT-PCR)
RT-PCR was performed according to the manufacturer’s protocol (Access
RT-PCR system, Promega). Total RNA was isolated from mouse
hippocampus as described above and reverse transcribed (RT) using
AMV reverse transcriptase and random hexamers, and the mixtures
incubated at 481C for 45 min followed by 941C for 2 min. For PCR
amplification of Mcl1, the cDNA template resulting from RT of 0.1mg
equivalent of total RNA was used in a 50 ml reaction. The primers were:
Mcl1 forward [50-AGATCATCTCGCGCTACTTGC-30] and Mcl1 reverse
[50-AGGTCCTGTACGTGGAAGAACTC-30] (Sigma-Genosys, TX, USA).
Amplification consisted of 40 cycles (941C for 30 s, 601C for 1 min, 681C
for 2 min), followed by incubation at 681C for 7 min. In all, 5 ml of loading
dye was added to 15ml of the sample, electrophoresed through a 1%
agarose gel containing ethidium bromide, and visualized by UV
illumination. There are two isoforms of Mcl1, a long form constituted of
433 base pairs and a short form of 185 base pairs, and only the long form
was detected in the agarose gel. The bands were eluted, purified from the
gel (Qiagen, Chatsworth, CA, USA) and the cDNAs sequenced for
authentication.
Mcl1 immunohistochemistry
Mice were anesthetized (i.p.) with ketamine, xylazine, and acepromazine
(0.5–1 mg/kg), and perfused transcardially with 0.1 M PBS (pH 7.4),
followed by 4% PFA in 0.1 M PBS (pH 7.4). Brains were removed, post-
fixed overnight in 4% PFA, transferred to 30% sucrose/PBS, and stored at
41C. Coronal sections (40 mm thick) were cut in a cryostat at 201C, and
stored in Tris-buffered saline (0.1 M Tris–HCl; 0.15 M NaCl; pH 7.4) (TBS)
at 41C. Floating sections were incubated for 1 h with 1.5% normal goat
serum (NGS) in TBS, then incubated with anti-Mcl1 antibody (1 : 200, S-
19, Santa Cruz Tech., Santa Cruz, CA, USA), 1.5% NGS, and 0.25%
Triton X-100 overnight at 41C. The Santa Cruz Mcl1 antiserum was
obtained using the same sequence as that reported previously and
evaluated for specificity.31,32 After washing in TBS, sections were
incubated in biotinylated anti-rabbit antibody (1mg/ml) diluted in TBS with
1.5% NGS for 30 min, followed by three rinses in TBS for 5 min. Sections
were incubated in avidin-biotinylated horseradish peroxidase complex
(rabbit ABC staining system, sc-2018, Santa Cruz Tech.) for 30 min and
rinsed with TBS. The peroxidase reaction was detected by application of
DAB/TBS for 3 min. After rinsing in TBS, sections were mounted on slides,
dehydrated, cleared, and coverslipped. Regional staining intensity was
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graded on a scale of 0–4 scale (0¼ no visible staining, 4¼ intense
staining).
Western blotting
C57BL/6J and C3H/HeJ mice were killed at 12 and 24 h after pilocarpine-
induced SE, and the hippocampi were dissected. The tissues were
homogenized in lysis buffer containing 150 nM NaCl, 50 mM Tris–HCl, pH
8.0, 0.1% SDS, 1 mM DTT, 1 mM phenylmethylsulfonyl fluoride, and 50ml/g
tissue of protease inhibitor cocktail (104 mM AEBSF, 0.08 mM aprotinin,
2 mM leupeptin, 4 mM bestatin, 1.5 mM pepstatin A, 1.4 mM E-64, Sigma
P 8340, St. Louis, MO, USA). In all, 50 mg of protein (as determined by
standard BCA, Pierce, Rockford, IL, USA protein assay) in Laemmli buffer
was resolved on SDS–PAGE, followed by electroblotting onto poly-
vinylidene difluoride membrane. After blocking with blocking solution
(Amersham, Little Chalfont, Buckinghamshire, UK) in Tris-buffered
saline with Tween 20 (150 mM NaCl, 50 mM Tris–HCl, pH 8.0, and
0.05% Tween 20), the membranes were probed with Mcl1 antibody
(1 : 1000, S-19, Santa Cruz Tech., Santa Cruz, CA, USA). After binding
with horseradish peroxidase-conjugated secondary antibodies, blots
were visualized with an enhanced chemiluminescence (ECL) detection
system (Amersham Biosciences). The membrane was analyzed by
autoradiography. Mcl1 protein levels were digitally quantified using Scion-
Image/NIH image software.
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